← All Mutual Funds

BlackRock Health Sciences Term Trust

CIK: 0001785971 BMEZ Equity
Report date: 2026-02-24
AUM $1.1B
Expense Ratio
Category Equity
State MD
Fiscal Year End
Inception Date
Manager
Latest Filing 2026-02-24

About this Fund

BlackRock Health Sciences Term Trust is a leading mutual fund company specializing in asset management and investment solutions, dedicated to providing a diverse range of portfolio options to meet the evolving needs of investors. As a prominent player in the financial services industry, the company offers a broad spectrum of mutual funds, including equity, debt, and hybrid funds, each carefully crafted to cater to the unique objectives and risk tolerance of its investors. With a strong focus on wealth management, BlackRock Health Sciences Term Trust empowers investors to achieve their long-term financial goals through a systematic investment plan, or SIP, which enables them to invest a fixed amount of money at regular intervals, thereby promoting disciplined investing and mitigating the impact of market volatility. The company's investment strategy is centered around identifying high-growth potential opportunities in the healthcare sector, with a team of experienced professionals leveraging their expertise to create a well-diversified portfolio that balances risk and return. By combining rigorous research and analysis with a deep understanding of the market trends, BlackRock Health Sciences Term Trust is able to deliver consistent and sustainable investment performance, making it a trusted partner for investors seeking to navigate the complexities of the financial markets. With a commitment to transparency and accountability, the company provides investors with regular updates on their portfolio performance, enabling them to make informed decisions about their investments. BlackRock Health Sciences Term Trust's investor-centric approach has earned it a reputation as a reliable and customer-focused mutual fund company, with a strong emphasis on building long-term relationships with its clients. By prioritizing the needs and objectives of its investors, the company is able to tailor its investment solutions to meet their specific requirements, whether they are seeking aggressive growth, income generation, or capital preservation. The company's key strengths lie in its ability to leverage the expertise of its parent company, BlackRock, one of the world's largest asset management firms, while maintaining a specialized focus on the healthcare sector, which enables it to deliver unique insights and investment opportunities to its clients. As a result, investors trust BlackRock Health Sciences Term Trust to manage their wealth and help them achieve their financial aspirations, secure in the knowledge that their investments are being managed by a team of experienced professionals with a proven track record of success.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

92 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-05-10 002824100 Equity (Common)
2.06%
$22.00 175,604
2 ABBV AbbVie Inc Since 2026-05-10 00287Y109 Equity (Common)
1.28%
$13.66 59,784
3 A Agilent Technologies Inc Since 2026-05-10 00846U101 Equity (Common)
1.58%
$16.88 124,041
4 AGIO Agios Pharmaceuticals Inc Since 2026-05-10 00847X104 Equity (Common)
0.25%
$2.71 99,595
5 ALLO Allogene Therapeutics Inc Since 2026-05-10 019770106 Equity (Common)
0.04%
$0.48 348,877
6 ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 02043Q107 Equity (Common)
0.23%
$2.46 6,196
7 COR Cencora Inc Since 2026-05-10 03073E105 Equity (Common)
0.49%
$5.20 15,383
8 AMGN Amgen Inc Since 2026-05-10 031162100 Equity (Common)
1.39%
$14.82 45,282
9 APGE Apogee Therapeutics Inc Since 2026-05-10 03770N101 Equity (Common)
0.29%
$3.08 40,862
10 ACLX Arcellx Inc Since 2026-05-10 03940C100 Equity (Common)
0.32%
$3.40 52,210
11 RCUS Arcus Biosciences Inc Since 2026-05-10 03969F109 Equity (Common)
0.37%
$3.95 165,805
12 ARVN Arvinas Inc Since 2026-05-10 04335A105 Equity (Common)
0.11%
$1.12 94,854
13 AZN AstraZeneca PLC Since 2026-05-10 046353108 Equity (Common)
1.00%
$10.64 115,738
14 AVTX Avalo Therapeutics Inc Since 2026-05-10 05338F306 Equity (Common)
0.05%
$0.56 30,621
15 AXSM Axsome Therapeutics Inc Since 2026-05-10 05464T104 Equity (Common)
0.49%
$5.25 28,760
16 BEAM Beam Therapeutics Inc Since 2026-05-10 07373V105 Equity (Common)
0.20%
$2.13 76,864
17 BIO-B Bio-Rad Laboratories Inc Since 2026-05-10 090572207 Equity (Common)
0.67%
$7.13 23,548
18 BMRN BioMarin Pharmaceutical Inc Since 2026-05-10 09061G101 Equity (Common)
0.18%
$1.88 31,662
19 BIIB Biogen Inc Since 2026-05-10 09062X103 Equity (Common)
1.51%
$16.18 91,947
20 BBOT BridgeBio Oncology Therapeutics Inc Since 2026-05-10 107924102 Equity (Common)
0.31%
$3.30 263,669
21 BBIO Bridgebio Pharma Inc Since 2026-05-10 10806X102 Equity (Common)
0.98%
$10.46 136,783
22 CRL Charles River Laboratories International Inc Since 2026-05-10 159864107 Equity (Common)
1.14%
$12.14 60,883
23 COGT Cogent Biosciences Inc Since 2026-05-10 19240Q201 Equity (Common)
0.23%
$2.50 70,345
24 DNLI Denali Therapeutics Inc Since 2026-05-10 24823R105 Equity (Common)
0.30%
$3.18 192,433
25 DXCM Dexcom Inc Since 2026-05-10 252131107 Equity (Common)
1.08%
$11.50 173,259
26 IRON Disc Medicine Inc Since 2026-05-10 254604101 Equity (Common)
0.15%
$1.57 19,760
27 DYN Dyne Therapeutics Inc Since 2026-05-10 26818M108 Equity (Common)
0.15%
$1.58 80,931
28 EWTX Edgewise Therapeutics Inc Since 2026-05-10 28036F105 Equity (Common)
0.21%
$2.21 89,151
29 ENTA Enanta Pharmaceuticals Inc Since 2026-05-10 29251M106 Equity (Common)
0.10%
$1.10 69,729
30 ELVN Enliven Therapeutics Inc Since 2026-05-10 29337E102 Equity (Common)
0.08%
$0.84 54,885
31 EXEL Exelixis Inc Since 2026-05-10 30161Q104 Equity (Common)
0.86%
$9.21 210,176
32 EYPT EyePoint Inc Since 2026-05-10 30233G209 Equity (Common)
0.13%
$1.37 75,092
33 FDMT 4D Molecular Therapeutics Inc Since 2026-05-10 35104E100 Equity (Common)
0.03%
$0.31 41,862
34 GILD Gilead Sciences Inc Since 2026-05-10 375558103 Equity (Common)
2.47%
$26.36 214,745
35 GOSS Gossamer Bio Inc Since 2026-05-10 38341P102 Equity (Common)
0.02%
$0.19 60,195
36 GH Guardant Health Inc Since 2026-05-10 40131M109 Equity (Common)
2.12%
$22.61 221,348
37 HALO Halozyme Therapeutics Inc Since 2026-05-10 40637H109 Equity (Common)
0.40%
$4.25 63,226
38 HRMY Harmony Biosciences Holdings Inc Since 2026-05-10 413197104 Equity (Common)
0.19%
$1.99 53,126
39 HOLX Hologic Inc Since 2026-05-10 436440101 Equity (Common)
0.96%
$10.22 137,197
40 ILMN Illumina Inc Since 2026-05-10 452327109 Equity (Common)
1.43%
$15.26 116,338
41 IMNM Immunome Inc Since 2026-05-10 45257U108 Equity (Common)
0.14%
$1.53 71,450
42 ISRG Intuitive Surgical Inc Since 2026-05-10 46120E602 Equity (Common)
1.25%
$13.35 23,573
43 IONS Ionis Pharmaceuticals Inc Since 2026-05-10 462222100 Equity (Common)
1.10%
$11.76 148,696
44 IQV IQVIA Holdings Inc Since 2026-05-10 46266C105 Equity (Common)
0.99%
$10.54 46,747
45 KALV KalVista Pharmaceuticals Inc Since 2026-05-10 483497103 Equity (Common)
0.11%
$1.14 70,390
46 KOD Kodiak Sciences Inc Since 2026-05-10 50015M109 Equity (Common)
0.10%
$1.03 36,966
47 KYMR Kymera Therapeutics Inc Since 2026-05-10 501575104 Equity (Common)
0.10%
$1.08 13,937
48 LBRX LB Pharmaceuticals Inc Since 2026-05-10 50180M108 Equity (Common)
0.43%
$4.63 207,987
49 LNTH Lantheus Holdings Inc Since 2026-05-10 516544103 Equity (Common)
0.30%
$3.21 48,294
50 MBX MBX Biosciences Inc Since 2026-05-10 55287L101 Equity (Common)
0.38%
$4.05 128,549
51 MAZE Maze Therapeutics Inc Since 2026-05-10 578784100 Equity (Common)
0.17%
$1.85 44,725
52 MRK Merck & Co Inc Since 2026-05-10 58933Y105 Equity (Common)
2.61%
$27.89 264,989
53 MRNA Moderna Inc Since 2026-05-10 60770K107 Equity (Common)
1.09%
$11.69 396,289
54 NTRA Natera Inc Since 2026-05-10 632307104 Equity (Common)
1.78%
$18.98 82,862
55 NBIX Neurocrine Biosciences Inc Since 2026-05-10 64125C109 Equity (Common)
1.06%
$11.30 79,676
56 NGNE Neurogene Inc Since 2026-05-10 64135M105 Equity (Common)
0.07%
$0.75 36,199
57 NUVL Nuvalent Inc Since 2026-05-10 670703107 Equity (Common)
0.49%
$5.23 52,024
58 NUVB Nuvation Bio Inc Since 2026-05-10 67080N101 Equity (Common)
0.24%
$2.54 283,833
59 NUVB Nuvation Bio Inc Since 2026-05-10 67080N119 Derivative
0.00%
$0.02 68,880
60 OCUL Ocular Therapeutix Inc Since 2026-05-10 67576A100 Equity (Common)
0.09%
$0.93 76,913
61 OLMA Olema Pharmaceuticals Inc Since 2026-05-10 68062P106 Equity (Common)
0.23%
$2.48 98,993
62 ORIC ORIC Pharmaceuticals Inc Since 2026-05-10 68622P109 Equity (Common)
0.08%
$0.81 99,005
63 ORKA Oruka Therapeutics Inc Since 2026-05-10 687604108 Equity (Common)
0.14%
$1.47 48,426
64 PTCT PTC Therapeutics Inc Since 2026-05-10 69366J200 Equity (Common)
0.24%
$2.61 34,361
65 PEN Penumbra Inc Since 2026-05-10 70975L107 Equity (Common)
0.55%
$5.84 18,775
66 NVS Novartis AG Since 2026-05-10 Equity (Common)
1.35%
$14.38 104,397
67 PFE Pfizer Inc Since 2026-05-10 717081103 Equity (Common)
0.39%
$4.13 166,019
68 PTGX Protagonist Therapeutics Inc Since 2026-05-10 74366E102 Equity (Common)
0.56%
$6.01 68,855
69 RDNT RadNet Inc Since 2026-05-10 750491102 Equity (Common)
0.31%
$3.35 46,906
70 RGNX REGENXBIO Inc Since 2026-05-10 75901B107 Equity (Common)
0.11%
$1.17 81,282
71 RVMD Revolution Medicines Inc Since 2026-05-10 76155X100 Equity (Common)
0.35%
$3.74 46,968
72 RZLT Rezolute Inc Since 2026-05-10 76200L309 Equity (Common)
0.02%
$0.26 108,605
73 RYTM Rhythm Pharmaceuticals Inc Since 2026-05-10 76243J105 Equity (Common)
1.12%
$11.93 111,452
74 SGMT Sagimet Biosciences Inc Since 2026-05-10 786700104 Equity (Common)
0.12%
$1.30 220,227
75 STOK Stoke Therapeutics Inc Since 2026-05-10 86150R107 Equity (Common)
0.39%
$4.21 132,656
76 SMMT Summit Therapeutics Inc Since 2026-05-10 86627T108 Equity (Common)
0.19%
$2.03 116,250
77 TEM Tempus AI Inc Since 2026-05-10 88023B103 Equity (Common)
0.43%
$4.59 77,823
78 TERN Terns Pharmaceuticals Inc Since 2026-05-10 880881107 Equity (Common)
0.53%
$5.67 140,311
79 TMO Thermo Fisher Scientific Inc Since 2026-05-10 883556102 Equity (Common)
0.49%
$5.25 9,062
80 TCRX TScan Therapeutics Inc Since 2026-05-10 89854M101 Equity (Common)
0.04%
$0.41 407,010
81 UPB Upstream Bio Inc Since 2026-05-10 91678A107 Equity (Common)
0.14%
$1.53 56,530
82 VIR Vir Biotechnology Inc Since 2026-05-10 92764N102 Equity (Common)
0.05%
$0.50 82,723
83 VOR Vor BioPharma Inc Since 2026-05-10 929033207 Equity (Common)
0.05%
$0.57 43,710
84 VYGR Voyager Therapeutics Inc Since 2026-05-10 92915B106 Equity (Common)
0.05%
$0.56 141,787
85 WST West Pharmaceutical Services Inc Since 2026-05-10 955306105 Equity (Common)
0.86%
$9.21 33,461
86 NYXH Nyxoah SA Since 2026-05-10 Equity (Common)
0.05%
$0.52 112,019
87 ALKS Alkermes PLC Since 2026-05-10 Equity (Common)
0.34%
$3.60 128,760
88 BHVN Biohaven Ltd Since 2026-05-10 Equity (Common)
0.05%
$0.53 46,808
89 KNSA Kiniksa Pharmaceuticals International Plc Since 2026-05-10 Equity (Common)
0.25%
$2.64 64,037
90 MDT Medtronic PLC Since 2026-05-10 Equity (Common)
2.68%
$28.63 298,077
91 ROIV Roivant Sciences Ltd Since 2026-05-10 Equity (Common)
0.49%
$5.22 240,456
92 WVE WaVe Life Sciences Ltd Since 2026-05-10 Equity (Common)
0.15%
$1.64 96,283
Frequently Asked Questions — BlackRock Health Sciences Term Trust
What type of mutual fund is BlackRock Health Sciences Term Trust?
BlackRock Health Sciences Term Trust is a SEC-registered Equity fund, with $1.1B in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, BlackRock Health Sciences Term Trust holds 92 portfolio positions, all detailed in the holdings table on this page.
What are BlackRock Health Sciences Term Trust's assets under management (AUM)?
BlackRock Health Sciences Term Trust has $1.1B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are BlackRock Health Sciences Term Trust's top holdings?
According to BlackRock Health Sciences Term Trust's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, AbbVie Inc, Agilent Technologies Inc , among others. The complete list of all 92 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is BlackRock Health Sciences Term Trust's expense ratio?
Expense ratio data for BlackRock Health Sciences Term Trust is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find BlackRock Health Sciences Term Trust's SEC filings?
BlackRock Health Sciences Term Trust is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001785971. You can access all of BlackRock Health Sciences Term Trust's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0001785971). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is BlackRock Health Sciences Term Trust's holdings data on StockSifting?
Holdings data for BlackRock Health Sciences Term Trust on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.